On 30 October 2014

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 October 2014 to consider and approve the Company's Unaudited Financial Statements for the Second Quarter/Half year ended 30 September, 2014 (Q2).

Powered by Capital Market - Live News

More From This Section

First Published: Oct 17 2014 | 1:47 PM IST

Next Story